IntelePeer Launches Aqurio | Trase Raises $107M Seed Round Led by ARCH Venture Partners. July 21, 2026 Check out today's featured companies who have recently raised a round of funding, and be sure to check out the full list of past healthcare IT fundings. IntelePeer Launches Aqurio, an Agentic AI Company for Healthcare and Other High-Stakes Industries Company's Mission is to Help Organizations in Complex Industries Operate More Efficiently and Scale Faster by Combining Agentic AI with Compliance-First Vertical Integrations IntelePeer today announced the launch of Aqurio, an Agentic AI company purpose-built to deploy, orchestrate, and govern intelligent AI agents across healthcare and other mission-critical industries. Designed for environments where mistakes carry financial and operational consequences, Aqurio delivers the enterprise-grade governance and reliability required to operationalize AI at scale. The launch brings together IntelePeer's AI technology, industry-specific expertise, customer relationships, proprietary interaction data, and enterprise infrastructure under a dedicated company built to meet the demands of organizations where trust and compliance are non-negotiable. IntelePeer continues to serve its CPaaS and voice services customers. Organizations across complex industries face a common set of pressures, including rising labor costs, increased regulatory oversight, persistent workforce shortages, fragmented systems, and customers and patients who expect immediate, personalized, and frictionless experiences across every interaction. Legacy technologies and traditional automation solutions have struggled to keep pace, creating disconnected experiences, operational inefficiencies, and growing costs that erode revenue, productivity, and trust. Aqurio is purpose-built to close these gaps, enabling organizations to deliver on the promise of the digital front door. Where traditional conversational AI understands and responds, Agentic AI takes the next step, operating within governance frameworks to make decisions and complete work autonomously. Aqurio agents execute end-to-end operational workflows across systems, departments, and channels that have historically required large teams to coordinate. In healthcare, Aqurio agents support patient access and adjacent workflows, including scheduling, prior authorization support, care gap closure, revenue recovery, and clinical triage support as defined and overseen by healthcare professionals. Across financial services, insurance, government, and other high-stakes industries, agents automate customer service, scheduling and appointment management, claims and payment workflows, collections, and other operational processes that demand accuracy, compliance, and accountability. By coordinating conversations, applying business rules, and executing tasks from initiation through completion, Aqurio's SmartAnalytics, SmartAgent, and SmartEngage operate as a unified agentic platform where every interaction continuously improves the next... Trase Raises $107M Seed Round Led by ARCH Venture Partners to Continue Building Agentic Operating System for Regulated Industries Trase has raised a $107M seed round led by ARCH Venture Partners with participation from Red Cell Partners and others. Led by CEO Grant Verstandig and President Baskar Sridharan, Trase is a full-stack AI solution providing an agentic operating system and agents for high-stakes environments. With a suite of hundreds of agents ready to deploy across multiple verticals in weeks, rather than months, Trase ensures compliance and governance across every workflow to drive real-world performance and unlock value creation for enterprise organizations. "Regulated industries are full of brilliant people who can exponentially serve their country and their customers through the power of AI. Trase delivers that boost to augment capabilities," said Robert Nelsen, Co-Founder and Managing Director at ARCH Venture Partners. "Grant has built the right team, the right technology, and has proven it works in industries that are the most demanding for performance." Since its launch last fall, Trase has been working with Duke University Health System to deploy specialized agents within its Division of Cardiology. Proven use cases include automating the more than 5,000 faxes the clinic receives each month, which were previously hand-sorted by trained medical assistants or nurses. While peer-reviewed research on the deployment of Trase agents at Duke is upcoming, initial observations from live agents reveal that AI routing...

Ex-Gov Youngkin cashes in with Tysons defense-tech power player. Published on July 15, 2026 Former Virginia governor Glenn Youngkin is sliding back into the private-sector spotlight, signing on with Tysons-based investment and incubation outfit Red Cell Partners. The move drops the onetime private-equity executive squarely back into Northern Virginia's startup and defense-tech scene and marks his first major business role since leaving office earlier this year. According to the Washington Business Journal, Youngkin is returning to his investment roots by joining the Tysons-area firm after a long run in private equity and a four-year stint in Richmond. For a company that has been quietly collecting big names from the Pentagon and industry circles, his arrival is a headline hire. What Red Cell does and who it hires. Red Cell Partners operates out of the McLean and Tysons corridor, backing startups in health care, cyber and national-security technology. That focus has helped pull in a roster of high-profile figures from both government and industry. The firm previously tapped former Defense Secretary Mark Esper to lead its national-security practice, a move that highlighted just how aggressively Red Cell is courting senior defense and policy experience. Reporting by Defense News provides background on those hires and the firm's focus areas. Youngkin's business and political background. Before his political turn, Youngkin spent roughly 25 years at The Carlyle Group, eventually rising into top management before stepping away to run for governor. The National Governors Association notes that he served as Virginia's 74th governor from January 15, 2022, to January 17, 2026, making this a relatively fast pivot back into the investment world. Red Cell is widely seen as leaning on his private-equity resume and deep network as it builds out its portfolio. Why the hire matters locally. Youngkin's addition reinforces a familiar Northern Virginia pattern: firms that live at the intersection of national security, venture capital and federal contracting keep pulling in big-name political and defense talent. In a region where government relationships can make or break a company's growth, parking a recent governor inside a Tysons investment shop sends a clear signal about how closely business and politics remain intertwined. The Washington Business Journal situates the hire squarely within that broader regional trend. Public materials from Red Cell outline the firm's leadership and recent press coverage, and its newsroom at Red Cell Partners is expected to offer more detail on Youngkin's specific responsibilities and title. For now, observers are watching how his political profile and dealmaking background might factor into Red Cell's push to scale its health-tech and national-security portfolio.